SDIC Venture Capital

SDIC Venture Capital Management Co., Ltd. is a Beijing-based investment firm established in 2016, focusing on sectors such as smart manufacturing, integrated circuits, artificial intelligence, network security, new materials, consumer products, information technology, environmental protection, new energy, biopharmaceuticals, and healthcare. The firm is a subsidiary of the State Development & Investment Corporation, a state-owned entity aimed at driving economic development in China. SDIC Venture Capital manages several funds with total assets amounting to 14 billion RMB. The firm prioritizes investments aligned with national strategic industries and key research initiatives, emphasizing technological innovation and the implementation of national development strategies. By fostering collaborations between government, society, and the market, SDIC Venture Capital aims to facilitate the transformation of scientific and technological advancements into practical applications while ensuring a return on investment.

Zhuoxi Chen

VP

Zhi Xiao

Managing Partner

98 past transactions

Life Biosciences

Series A in 2023
Life Biosciences provides animal behaviour analysis services. Their services include blood biochemistry, routine blood testing, pathological staining, immunohistochemistry, fluorescence, molecular experiments, cell experiments, flow cytometry, x-ray irradiation, and nuclear magnetic resonance.

SinceVision

Series C in 2023
SinceVision is a manufacturing company that provides high-speed cameras, 3D laser profilers, sensors, and technical support services.

Hongfucheng

Venture Round in 2023
Hongfucheng engages in the integration of research, development, manufacturing, and sales of materials such as EMI shielding materials, thermal interface materials, and wave-absorbing materials.

Zhishan Weixin Biotechnology

Series A in 2023
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.

Yike Polymers

Series B in 2023
Eco Polymer specializes in designing and manufacturing plastic tubes and parts. They provide products for polyethylene, polypropylene, polyamine, elastomers, fluoropolymers, and other various polymers. They serve the medical instrument, auto, electronics, fiber optics, semiconductor, chemical engineering, environment, and analytics industries.

Viiyong

Series B in 2022
Viiyong is a manufacturer of multi-layer ceramic chip capacitors. The company was founded in 2001 and is based in Shenzhen, China.

Dakang Medical

Series E in 2022
Dakang Medical is a chain of independent blood purification medical service institutions. Dakang Medical is a company whose leading industries are medical investment, medical institution management, and brand operation services.

TBSTest Technology

Venture Round in 2022
Yuexin Technology is a semiconductor test equipment developer specializing in R&D, production and sales of ultra-large-scale integrated circuit test equipment (ATE). Its main product is SOC test equipment, which is mainly for enterprise users of integrated circuit design, production, packaging and testing. Integrated circuit test equipment and solutions.

Ouye Semiconductor

Seed Round in 2022
Ouyeel Semiconductor is a manufacturer of SoC chips. They offer smart car chips and solutions for automakers, enabling customers to reduce costs and time to develop new products and features.

Yuansheng Pixel

Seed Round in 2022
Pixel offers AI, data algorithm, neural expansion that solves data technology problems and provides intelligent marketing solutions .
Weikaier Pharmaceutical provides R&D of innovative drugs, transfer of generic drug technology, the production and sales of pharmaceuticals.

Beilai Bio

Series B in 2022
Beilai Bio is a clinical-stage biopharmaceutical company focused on the development of stem cell therapeutics for various diseases, particularly those with high unmet medical needs. Its established technology platforms allow them to produce clinical-grade "off-the-shelf" Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC) from an unlimited supply of cord tissues that are traditionally regarded as medical waste.

Yihui Information

Series B in 2022
Yihui Information provides technical assistance and integrated hardware and software solutions. They also offer development kits, virtualization, cloud native that includes mission-critical cloud native, microservices architecture, container management services, and more.

G7

Private Equity Round in 2022
G7 has an installation base of 800,000 cargo vehicles throughout China. Through its proprietary hardware devices, the company is able to compile data for logistics companies and drivers on location, route optimization, fuel consumption, and cargo status (temperature, humidity, etc).

Ractigen Therapeutics

Series A in 2022
Ractigen is an early-stage pharmaceutical company committed to bringing to market first-in-class therapies designed to selectively restore the expression of therapeutic genes silenced in diseased cells. Its core technology is based on a paradigm-shifting discovery made at the University of California San Francisco (UCSF) known as RNA activation (RNAa). Founded in 2016 by the pioneers in the field, Ractigen is developing a rich pipeline of candidate medicines for patients with unmet need.

Air Touch

Series C in 2022
Air Touch is a Fvss dedicated to RF and microwave integrated circuit design companies, providing solutions for chips, modules, algorithms, software and even intelligent terminals. Become the world's leading supplier of microwave and millimeter wave radar chips and solutions. The technology is derived from the miniature millimeter wave short-range radar detector in the military industry. It has applied for more than 10 invention patents and has strong financial strength to support the company's sustainable development. The company dares to adopt first-class technical solutions to locate and develop world-class technology. Chip products.

Borui Jixin

Series D in 2022
Borui Jixin is a military-civilian integrated electronic information product supplier. The company focuses on the R&D and production of complete equipment and core chips in the fields of communications, radar, avionics and other fields. The products include monolithic drive amplifiers and parallel CNC attenuators. , Thin film power divider, etc.

MoonBiotech

Series C in 2021
MoonBiotech is a biotechnology company focused on the commercialization of microbial resources.

Gongda Satellite

Series A in 2021
Gongda Satellite is a commercial aerospace company that designs, manufactures on-orbit delivery commercial satellite products.

Jinyi New Material

Venture Round in 2021
Ginet New Material is a technology company providing R&D and production of inorganic non-metallic powder new material application solutions.

Time Speed

Series B in 2021
Time Speed ​​is a radio frequency integrated circuit developer, which can provide monolithic microwave integrated circuits, radio frequency integrated circuits, gallium arsenide gallium nitride power amplifier chips, low noise amplifier chips, and radio frequency front-end module chips for users in the 4G/5G communications market. And other products.

Sinomicro Medical

Series C in 2021
Sinomicro Medical is a medical device firm focused on the development of tumor ablation treatment with minimally invasive surgical robots.

Weishi Energy

Series A in 2021
Weishi Energy is a hydrogen fuel cell product research and development manufacturer, focusing on the market operation of hydrogen fuel cell technology, and is committed to promoting the low-carbon sustainable development of human energy. It is mainly engaged in the research and development, production and sales of hydrogen fuel cell products. At present, Weishi Energy has deployed five R&D centers in Shanghai, Baoding, Japan, Germany, and Canada. It has established a culturally diverse and technologically advanced R&D team, and strictly follows the V model development process to create vehicle-level fuel cell power systems and components. The company's main products include fuel cell engines, electric stacks, 35MPa/70MPa on-board hydrogen systems, bottle valves and pressure reducing valves, etc.
The founding team of Vipas Semiconductor is composed of high-tech technical experts and market management experts from home and abroad. Relying on Nanjing University's independent innovation of vertical charge transfer imaging device (VPS) technology, it focuses on a new generation of new sensor imaging chip technology products. A high-tech company that develops and manufactures.

Immunochina

Series D in 2021
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

Guangdong Xinjuneng

Venture Round in 2021
Xinjuneng Semiconductor is a semiconductor device manufacturer integrating design, research and development, and production. It is mainly oriented to the new energy vehicle and power semiconductor application market, providing users with power semiconductor packaging, modules and other products.

Yingmai Medical

Series B in 2021
Yingmai Medical offers solutions for valve intervention, aortic and peripheral intervention, and neuromodulation. They are covering multiple innovative technology fields, such as structural heart disease treatment, pan-vascular disease treatment, nerve stimulation, and a brain-computer interface platform.

Hestia Power

Series A in 2021
Hestia Power is a SiC and GaN power semiconductor technology and product development firm. They provide semiconductor power devices and power modules. Their products include SiC power semiconductors and wide-bandgap power modules.

Bo Shi Ran

Venture Round in 2021
Bo Shi Ran is a cotton harvester that provides mechanized solutions for cotton planting, integrating R&D, production, sales, and service.

Inceptio Technology

Series B in 2021
Inceptio Technology provides a nationwide freight network using autonomous driving trucks. It focuses on the transformation of line-haul logistics by providing a more secure, efficient, and economical Transportation-As-A-Service to logistic customers. The company's autonomous driving heavy-duty trucks utilize artificial intelligence technology, new energy technology, and logistics big data technology, providing logistics companies with efficient and safe logistic solutions. It was founded in 2018 and is based in Shanghai, China. It has R&D centers in both Shanghai and Silicon Valley.

SVOLT

Series B in 2021
SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energy vehicle charging piles, batteries recycling, and solutions.

Joyo Pharma

Series B in 2021
Joyo Pharma focuses on the research and development of drugs for the treatment of tumors, autoimmunity, metabolism, and infectious diseases.

Huitongda

Series E in 2021
Huitongda (汇通达) is a Chinese logistics service company providing home appliance supply chain services for the township market. The company is mainly focused on household appliance categories such as air-conditioning, color TV, refrigerator, washing machine, kitchen, and others. Huitongda’s business strategy combines online and offline sales, and it pays special attention to the market of township household appliances. The company has branches that cover the Jiangsu province and some areas of Shandong and Anhui, and has trained more than 3000 retail outlets in China’s township. Headquartered in Nanjing, Huitongda was established in January 2008.

Just Medical

Series B in 2021
Just Medical is an artificial orthopedic implant device and system developer. Just Medical provides hip knee and average staircase therapy for all surgical product solutions. Just Medical is committed to providing medical products and services that are safe and effective. It maintains high-speed development, and excellence, and gradually improves the product system in order to help doctors and end the patient's pain.

Porton Advanced Solutions

Series A in 2021
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.

Abogen Biosciences

Series B in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Afecta Pharmaceuticals

Series A in 2021
Aucta Pharmaceuticals is a Shanghai-based company that specializes in researching and developing pharmaceutical drugs aimed at improving drug delivery and enhancing label effectiveness. With an additional office in Princeton, New Jersey, Aucta focuses on creating novel and niche generic medical products using a drug development platform characterized by poorly water-soluble formulations and controlled release mechanisms. The company primarily targets central nervous system and oncology compounds, allowing pharmaceutical partners to develop drugs that better align with patient compliance needs. Through its innovative approach, Aucta Pharmaceuticals aims to advance the development and commercialization of branded specialty products and niche generics in the pharmaceutical industry.

BGI Group

Post in 2021
Shenzhen Huada Gene Technology Co. Ltd. operates as a biotech development company. The Company provides bioinformatics testing, genetic testing, agricultural genomics researching, proteomics researching, and other services. Shenzhen Huada Gene Technology conducts business in China.

Tianfu

Series B in 2021
Tianfu is a software enterprise. The company serves domestic and foreign manufacturing companies, domestic military units, universities, and scientific research institutes. The company's services include smart design solutions, industrial AI operation and maintenance, and software custom development. It also provides customized development services for corporate customers, including CAE pre-processing development.

rivamed

Series B in 2021
Rivamed provides logistics management systems and medical material management solutions based on the internet of things technology that help integrate medical resources. They also provide medical solutions for closed-loop management of medical intelligent IoT through independent innovation and deliver advanced management concepts. They also provide medical devices, printers, and drug management cabinets.

Jaka Robot

Series C in 2021
Jaka Robot is a Shanghai-based industrial robot developer company.

Zhiyi Pharmaceutics

Series B in 2020
Founded in 2013, Zhiyi Bio focuses on the research and development of second-generation probiotics and Live Biotherapeutics. Based on the discovery of strains and drug development with independent intellectual property rights, a lot of innovative research has been carried out, and the “Know-How” from strains to drugs has been established, and the innovative live bacteria drug SK08 is about to enter the clinic. On this basis, Zhiyi will continue to strengthen the research and development of the relationship between human microbiome and disease, including microbial culture group and pathobionts research, target determination and separation of new functional strains.

Synlight Crystal

Series A in 2020
Synlight Semiconductor is a silicon carbide substrate manufacturing company. They provide stable SiC wafers to downstream customers. It currently manufactures N-type and semi-insulating SiC wafers.

Abogen Biosciences

Series A in 2020
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

JOYNEXT

Venture Round in 2020
Joy Next is a smart cockpit and automobile systems platform.

WM Motor

Series D in 2020
WM Motor is an automotive company that designs, manufactures, develops, and markets energy and battery-operated vehicles. It provides energy vehicle products and travel solutions to its customers. The company aims to conserve electronic vehicles in addition to intelligent data hardware, enabling consumers to utilize smart cars that are efficient and energy conserving. WM Motor’s products are built with three core technologies, the Living Motion electric powertrain, the Living Pilot intelligent driving assistance system, and the Living Engine operating system, which offers industry-leading smart connectivity and interactive features.

Biocytogen

Series D in 2020
Biocytogen is a biopharmaceutical company that provides biomedical communities with integrated solutions for antibody drug development. Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMabTM Mouse), and in vivo/in vitro preclinical validation studies, using gene editing technologies and a state-of-the-art animal facility. Biocytogen works with the world's leading pharmaceutical and biotechnology companies.

XuanZhu Pharma

Series A in 2020
XuanZhu Pharma is an innovative biopharmaceutical company rooted in China, with a global perspective, focusing on tumors, metabolic diseases, infections, and other fields. It has a layout of the entire industry chain from drug discovery, preclinical research, clinical development, and production and sales.

Everbright Photonics

Series C in 2020
Everbright Photonics works on the development, production, and marketing of essential laser industry parts like semiconductor laser chips, devices, and modules. The company is dedicated to the study and creation of moderate optical communication semiconductor laser chips, devices, and systems, efficiency laser radar, 3D sensor chips, and power semiconductor laser chips. The company's goods are employed in areas such as machine vision, sensing, biomedical cosmetology, high-speed optical communication, industrial laser pumping, and advanced laser production equipment.

MabPlex

Series B in 2020
MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs, and bispecifics. They offer partners contract services from DNA to finished drug product. They offer comprehensive biologics development and manufacturing solutions for customers globally.

DTstack

Series B in 2019
Kangaroo Cloud (quasi-unicorn enterprise) owns two digital technology subsidiaries, cloud technology and cloud technology, mainly for retail, finance, government, tourism, internet and other industries, providing digital stacks including DTinsight, data visualization, and data center solutions. Big data and cloud technology products and services, including solutions and cloud MSPs, help companies achieve digital transformation and promote industrial innovation and social progress.

HQ Education

Series A in 2019
HQ Education is engaged in the enterprise of digitalizing science and technology services for education. They provide easy-to-use software applications and SaaS service systems for basic education. They offer education technology, academic improvement, teacher training, school hardware, college entrance examinations, and many more.

Remegen

Private Equity Round in 2019
RemeGen, Ltd. ("RemeGen") is a biopharmaceutical company in China dedicated to fulfilling unmet medical needs for patients with life-threatening conditions. RemeGen's main focus is research and development, manufacturing and commercialization of novel biologics, most notably monoclonal antibodies (mAb) and antibody-drug conjugates (ADCs). Headquartered in Yantai, Shandong Province, China, RemeGen has labs/offices in Beijing and California.

PhotonIC Technologies

Series C in 2019
PhotonIC Technologies is a stealth-mode chip company. It develops integrated photo-electronic chips for next-generation optical networking and IOT sensing systems. The company is based in Shanghai, China.

Casiris

Series D in 2019
Casiris Vision is a limited liability company jointly invested by the Institute of Physics and Chemistry of the Chinese Academy of Sciences, Hangzhou Economic and Technological Development Zone, venture capital and technical team. The company is committed to R&D and production challenges. A pure laser display product with a human visual limit. In 2016, it was recognized as a national high-tech enterprise, a high-tech enterprise in Hangzhou, a technology-based enterprise in Zhejiang and Hangzhou Economic and Technological Development Zone. At present, Zhongke Aurora has 5,500 square meters of automated light source and complete machine production line, providing laser light source applications to home theater, engineering projection, film and lighting engineering complete solutions.

Biocytogen

Series D in 2019
Biocytogen is a biopharmaceutical company that provides biomedical communities with integrated solutions for antibody drug development. Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMabTM Mouse), and in vivo/in vitro preclinical validation studies, using gene editing technologies and a state-of-the-art animal facility. Biocytogen works with the world's leading pharmaceutical and biotechnology companies.

Bai Xiniu

Angel Round in 2019
Bai Xiniu offers 3D panoramic camera for the real estate industry.

Bangsun Technology

Series C in 2019
Bangsun Technology is a Hangzhou-based real-time financial risk management company. It provides services including payment anti-fraud, application anti-fraud, Internet lending, data service, robot defense and anti-money laundering for financial institutions.

Allist Pharmaceuticals

Series A in 2019
Allist Pharmaceuticals is a pharmaceutical enterprise that discovers, develops, and commercializes innovative medicines. Allist Pharmaceuticals is oriented by unmet clinical demands in the global pharmaceutical market, with a special focus on tumor treatment, under the development concept of advancing long life through scientific and technological innovation. Allist Pharmaceuticals develops medicines with the commitment to creating safe, effective, and inclusive innovative drugs with independent intellectual property rights.

Intelligent Laser

Series B in 2019
Intelligent Laser is a developer of robotic laser vision systems, mainly engaged in the development and production of laser vision systems. At the same time, it cooperates with Tangshan Yinglai Machine Vision Engineering Technology Application Center to provide users with solutions for laser vision sensors for industrial robots.

NationalChip

Series B in 2019
Hangzhou Guoxin focuses on chip design and system solution development in the fields of digital TV, home multimedia and artificial intelligence. The company has developed digital TV chip products all over the world and is one of the world's leading suppliers of set-top box chips.

Biostar Technologies

Series B in 2019
Beijing Biostar Technologies, Ltd. was incorporated in Haidian Park, Zhongguancun Science and Technology Park, Beijing, in July 2002. The national high-tech led by the team of Chinese scientists in the United States led by Dr. Tang Li and Dr. Qiu Rongguo. The company, focusing on biomedical development, technology and transfer of anti-tumor small molecule chemical drugs, and technical service consulting, pioneered the creation of new anti-cancer drugs for epothilone in China, and its technology is at the international advanced level.

MabPlex

Series A in 2019
MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs, and bispecifics. They offer partners contract services from DNA to finished drug product. They offer comprehensive biologics development and manufacturing solutions for customers globally.

BrightGene

Venture Round in 2019
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.

ZETTASTONE

Angel Round in 2018
Zettastone is engaged in solid-state storage technology based on flash memory chips. They provide solutions for PC manufacturers, financial and other industrial control fields, data centers, industrial automation, transportation, medical treatment, and telecommunications.

Everbright Photonics

Series B in 2018
Everbright Photonics works on the development, production, and marketing of essential laser industry parts like semiconductor laser chips, devices, and modules. The company is dedicated to the study and creation of moderate optical communication semiconductor laser chips, devices, and systems, efficiency laser radar, 3D sensor chips, and power semiconductor laser chips. The company's goods are employed in areas such as machine vision, sensing, biomedical cosmetology, high-speed optical communication, industrial laser pumping, and advanced laser production equipment.

SKYVERSE

Series B in 2018
Skyverse focuses on the R&D and production of industrial intelligent testing equipment. The SKYVERSE product line meets the majority of the optical measurement and inspection needs of semiconductor front-end and middle-end. SKYVERSE offers advanced optical detection technology and complete solutions for the integrated circuit front-end and advanced packaging industries, as well as precision processing and manufacturing.

Changhong Intelligence

Series B in 2018
Established in 1989, Changhong Intelligent is a professional company specialized in the planning and design of automotive factories, as well as the design, manufacturing, installation, commissioning and after-sales service of welding, coating and final assembly production line in automotive, aerospace and general industry sectors. Covering the land of 280,000 square meters, Changhong has a building area of 150,000 square meters, with the total registered capital of RMB 182 million and over 600 employees. Changhong is a key hi-tech enterprise under the National Torch Program and Trustworthy Enterprise, National Pilot Enterprise for Standardized Integration of Information and Industrialization. Company has set up a National-Level Postdoctoral Scientific Research Workstation and National-Level Enterprise Technical Center. Changhong is a well-known trademark in China. Changhong Intelligence has the first private design institute—Jiangsu Changhong Machinery Design Institute, which is a National Level Enterprise Technical Center, a Nationwide Postdoctoral Workstation and a Research Center of Automobile Coating Engineering. Featuring with the Class-A in machinery industry, the design institute embraces 6 well-known experts, 12 senior engineers and 108 engineers involving in mechanical engineering, electric, architecture, water supply and drainage, welding and informatization sectors. Besides, the design institute maintains a long-term industry-university-research cooperation relationship with Tsinghua University to develop 60 kinds of advanced high-tech products at home and abroad, among these products, the painting robots for automobile and the environmental protection flexibility compliant parallel mechanism conveyor for automobile coating automatic production line obtained Jiangsu Provincial Science and Technology Award, the Second-Class Award of Science and Technology in China’s mechanical engineering industry and the Outstanding Award of Scientific and Technological Progress in Yancheng.

Cambricon Technologies

Series B in 2018
Cambrian Technology is a pioneer in the field of smart chips in the world. It aims to build the core processor chips of various intelligent cloud servers, smart terminals and intelligent robots. Professor Chen Tianshi, founder and CEO of the company, is a distinguished young scientist renowned both at home and abroad in the field of processor architecture and artificial intelligence. He was awarded the honorary title of "Excellent Youth" by the National Natural Science Foundation of China, CCF-Intel Young Scholar Award, China Computer Society outstanding Doctoral Dissertation Award and other honors. The Cambrian is the world's first smart chip company with successful outflow and mature products, and has two product lines, terminal and server. The Cambrian-1A processor (Cambricon-1A), introduced in 2016, is the world's first commercial deep learning processor for smart phones, wearable devices, unmanned aerial vehicles, smart driving and other types of terminal equipment.

Robotleo

Series B in 2018
Robotleo is focused on the research and development of intelligent companion robots for home use.

Video++

Series B in 2018
Video++ provides video-streaming services for users within and outside China. It began operation in April 2014, with its headquarters in Shanghai in China.

Biocytogen

Series C in 2018
Biocytogen is a biopharmaceutical company that provides biomedical communities with integrated solutions for antibody drug development. Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMabTM Mouse), and in vivo/in vitro preclinical validation studies, using gene editing technologies and a state-of-the-art animal facility. Biocytogen works with the world's leading pharmaceutical and biotechnology companies.

Bangsun Technology

Series B in 2018
Bangsun Technology is a Hangzhou-based real-time financial risk management company. It provides services including payment anti-fraud, application anti-fraud, Internet lending, data service, robot defense and anti-money laundering for financial institutions.

DigiHuman

Post in 2018
DigiHuman is a project that studies and creates computerized human bodily systems. Their product categories include digital anatomy, morphology, 3D printing models, and touchable screens. The company is involved in the application, research, and development of digital human body systems. It is an application, research, and development of digital human anatomy systems, medical digital image processing, and a digital medical teaching platform. Their product line includes digital medical education, human life science, and digital medical products. The service targets hospitals, medical colleges, science and technology exhibition halls, and other fields.

YOYOSYS

Series D in 2018
YOYOSYS engages in the development and commercialization of key cloud computing and big data technologies. Government, public security, transportation, the military industry, telecommunications, finance, power and energy, retail manufacturing, etc. are some of the company's clients. They also work on integrating new-generation Internet technology and concepts into critical information infrastructure related to national security and economic survival.

KBP Biosciences

Series A in 2018
KBP is a world-class biotechnology research & development organization dedicated to providing innovative therapies for unmet medical needs.
Zhejiang Bluetron Industrial Internet Information Technology Co., Ltd. is located in Ningbo, Zhejiang, China and is part of the Computer Systems Design and Related Services Industry. There are 4 companies in the Zhejiang Bluetron Industrial Internet Information Technology Co., Ltd. corporate family.

OMNI

Series C in 2017
OMNI is an innovative pharmaceutical company focusing on the development of drug delivery technology. OMNI provides inhalation dosage forms, including inhalation aerosol, inhalation powder aerosol, inhalation nebulized solution, and nasal spray, and a design platform for supporting respiratory devices for asthma and chronic obstructive pulmonary disease.

Enmotech

Series B in 2017
Yunhe Enmo is dedicated to introducing data technology to every business and organization, as well as to creating a data-driven intelligent future. The company supplies consumers with dependable goods, services, and solutions in the domains of data management, transportation, processing, and application, and it works tirelessly to achieve an agile and efficient digital world in the future.

ECTEK

Post in 2017
ECTEK offers a customized and open electronic control platform to help customers integrate the entire power system based on the electronic control platform. They controlled the diesel engine control system, the gas engine control system, the pure electric power system, the AMT transmission system, the oil-electric hybrid power system, the fuel cell control system, the intelligent network connection, and the service.

OMNI

Series B in 2017
OMNI is an innovative pharmaceutical company focusing on the development of drug delivery technology. OMNI provides inhalation dosage forms, including inhalation aerosol, inhalation powder aerosol, inhalation nebulized solution, and nasal spray, and a design platform for supporting respiratory devices for asthma and chronic obstructive pulmonary disease.

Quadas

Series A in 2017
Quadas is a SaaS cloud advertising technology company that offers mobile programmatic cloud solutions for customers. They build transparent mobile DSP and data management platforms to improve the customer's data management abilities and provide programmatic advertising technology for digital marketing companies.

Cambricon Technologies

Series A in 2017
Cambrian Technology is a pioneer in the field of smart chips in the world. It aims to build the core processor chips of various intelligent cloud servers, smart terminals and intelligent robots. Professor Chen Tianshi, founder and CEO of the company, is a distinguished young scientist renowned both at home and abroad in the field of processor architecture and artificial intelligence. He was awarded the honorary title of "Excellent Youth" by the National Natural Science Foundation of China, CCF-Intel Young Scholar Award, China Computer Society outstanding Doctoral Dissertation Award and other honors. The Cambrian is the world's first smart chip company with successful outflow and mature products, and has two product lines, terminal and server. The Cambrian-1A processor (Cambricon-1A), introduced in 2016, is the world's first commercial deep learning processor for smart phones, wearable devices, unmanned aerial vehicles, smart driving and other types of terminal equipment.

Eucure Biopharma

Series A in 2017
Eucure Biopharma is a global biotechnology company headquartered in Beijing, China. They are committed to the discovery and development of innovative immuno-oncology targeted antibodies which mainly focus on immune checkpoints. Several products have entered the CMC stage and has applied for clinical trial in 2019. Their mission is to develop antibody treatments to improve the survival rate of tumor patients.

HiGo

Angel Round in 2017
HiGo is an intelligent driving control system developer company.

Realmax

Series A in 2017
Realmax is an augmented reality company headquartered in Shanghai, with offices in Shanghai, Hong Kong and New York.

Feilongyu

Angel Round in 2017
Feilongyu offers bottled water for consumption. The process consists of several different steps, such as automatic internal, strict empty barrel, water treatment, laboratory test, automatic, finished light, automatic, and others.

Skyguard

Series A in 2017
Skyguard is a data security technology company. The company offers to develop data security technology centered on people and data. The company provides consulting, pre-sales, and after-sales technical support services for enterprise users.

Biocytogen

Series B in 2017
Biocytogen is a biopharmaceutical company that provides biomedical communities with integrated solutions for antibody drug development. Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMabTM Mouse), and in vivo/in vitro preclinical validation studies, using gene editing technologies and a state-of-the-art animal facility. Biocytogen works with the world's leading pharmaceutical and biotechnology companies.

Eucure Biopharma

Series A in 2016
Eucure Biopharma is a global biotechnology company headquartered in Beijing, China. They are committed to the discovery and development of innovative immuno-oncology targeted antibodies which mainly focus on immune checkpoints. Several products have entered the CMC stage and has applied for clinical trial in 2019. Their mission is to develop antibody treatments to improve the survival rate of tumor patients.

INVO Zhihua

Series B in 2016
INVO Zhihua is a developer of automotive driver assistance systems.

Ascentage Pharma

Series B in 2016
Ascentage Pharma develops novel small-molecule therapies for cancer, hepatitis B, and age-related diseases. They have developed a pipeline of seven drug candidates that disrupt complex and difficult-to-target protein-protein interactions and are next-generation tyrosine kinase inhibitors.

Innovent Biologics

Series D in 2016
Innovent Biologics, Inc. is a privately held biopharmaceutical company dedicated to developing and manufacturing monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by Fidelity's venture arm, a prominent investment firm in the US, Lilly Ventures, and Suzhou bioBay. The registered capital is 30 million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development, and manufacture of biologics in the US, Europe, and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others.
Twenty First Century Aerospace Technology offers remote sensing satellite operations and geospatial information big data services. They offer big data products for satellite remote sensing, such as 3D scene data products of satellites and satellite remote sensing data products. Their spatial information requires comprehensive application services, such as image application services, software application services, and a comprehensive application service.

Huangdi

Series B in 2015
Huangdi is engaged in the improvement of motor vehicle exhaust pollution. They provide research and development, a production base, technology application, and business operations. They also specialized in technology development, application development, and calibration matching.
Jilin Connell Pharmaceutical is a pharmaceutical manufacturing company. They produce oral solid preparations, mixtures, and oral liquids. It also provides thymosin enteric-coated tablets, which are also used clinically in the treatment of low-immunity diseases such as tumors, acute pancreatitis, and systemic lupus.

Huafeng

Angel Round in 2008
Huafeng provides optical connectors and interconnection solutions. They develop a range of products, from electrical ports to optical ports. Their products include circular connectors, rectangular connectors, printed circuit electrical connectors, RF coaxial connectors, cable assemblies, integrated components, car connectors, and more.

Zhejiang Xianju Pharmaceutical

Funding Round in 2001
Zhejiang Xianju Pharmaceutical Co., Ltd (仙琚制药) is a Chinese company manufacturing steroid drug products, steroid hormone medicines, and medicines for birth control. The company’s main business is focused on the development, production, and sale of raw materials and preparation of pharmaceutics for steroid drugs. Its products are based on three categories: corticosteroid drugs, sex hormone drugs (gynecological and birth control medication), and anesthesia and muscle relaxation drugs. These categories consist of more than 200 varieties of drugs. Currently, all the products of the company have passed the authentication of GMP. It has built a long-term partnership with more than twenty famous scientific research institutes and universities in China such as Shanghai Institute of Organic Chemistry and Chinese Pharmaceutical University. Xianju Pharmaceutical was established in 1972.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.